Biofirst S.A., headquartered in Belgium, is a prominent player in the biotechnology industry, specialising in innovative solutions for healthcare and agriculture. Founded in the early 2000s, the company has achieved significant milestones, establishing itself as a leader in the development of biopharmaceuticals and bio-based products. With a focus on sustainable practices, Biofirst S.A. offers a range of unique products, including advanced biopesticides and biofertilisers, designed to enhance crop yield while minimising environmental impact. The company’s commitment to research and development has positioned it at the forefront of the market, earning recognition for its contributions to sustainable agriculture. Operating primarily in Europe, Biofirst S.A. continues to expand its influence, driven by a dedication to innovation and quality. Its notable achievements underscore its role as a trusted partner in the biotechnology sector, committed to advancing both health and environmental sustainability.
How does Biofirst S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biofirst S.A.'s score of 14 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Biofirst S.A. reported total carbon emissions of approximately 27,719,300 kg CO2e from Scope 3, with significant contributions from waste generated in operations, amounting to about 2,860,400 kg CO2e. The company also recorded Scope 1 and 2 emissions of approximately 24,394,000 kg CO2e. This data reflects a substantial increase in emissions compared to 2019, when total Scope 3 emissions were about 1,375,000 kg CO2e, and Scope 1 and 2 emissions were approximately 19,867,000 kg CO2e. Biofirst S.A. is a current subsidiary of Floridienne S.A., which influences its emissions reporting. However, there are no specific reduction targets or climate pledges disclosed by Biofirst S.A. at this time. The absence of defined reduction initiatives suggests a need for enhanced climate commitments within the organisation.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2024 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | - | - |
| Scope 3 | 1,375,000 | 000,000,000 |
Biofirst S.A.'s Scope 3 emissions, which increased significantly last year and increased significantly since 2019, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Waste Generated in Operations" being the primary emissions source at 10% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biofirst S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.